David Lebwohl

NTLA

David Lebwohl serves as EVP, Chief Medical Officer at Intellia Therapeutics, Inc. (NTLA). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

10 trades

$2.37M

Net Position

Net Seller

$2.37M

Companies Traded

NTLA

Active Period

Aug 2021 – Jan 2026

10 total trades

Most Recent

Sell NTLA

Jan 5, 2026 · $109.6K

David Lebwohl's Insider Trading at Intellia Therapeutics, Inc. (NTLA)

Buys

0 · $0.00

Sells

10 · $2.37M

Total Shares Bought

Total Shares Sold

42,928

NTLA Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 5, 2026	Sell	11,903	$9.21	$109.6K	0
Jan 7, 2025	Sell	9,557	$12.18	$116.4K	87,666
Jan 5, 2024	Sell	5,843	$29.46	$172.1K	54,372
Jan 6, 2023	Sell	2,574	$37.21	$95.8K	25,687
Mar 3, 2022	Sell	1,051	$112.24	$118.0K	10,922
Nov 9, 2021	Sell	2,400	$132.72	$318.5K	9,914
Oct 15, 2021	Sell	2,400	$128.44	$308.2K	10,563
Sep 23, 2021	Sell	2,400	$149.81	$359.5K	791
Sep 1, 2021	Sell	2,400	$158.04	$379.3K	2,991
Aug 11, 2021	Sell	2,400	$164.05	$393.7K	791